mesenchymal stem-cell based oncolytic virus therapy (Orgenesis/Kurve Therapeutics)

N/A

Report date: 2025/01/26 17:24:27

Base Information

Drug Namemesenchymal stem-cell based oncolytic virus therapy (Orgenesis/Kurve Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrgenesis Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A